For the quarter ending 2025-09-30, IBRX has $518,987K in assets. $1,042,397K in debts. $60,241K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 60,241 | 137,658 | 60,660 | 143,428 |
| Marketable securities | 197,572 | 16,000 | 931 | 6,381 |
| Accounts receivable, net | 32,016 | 22,126 | 17,029 | 2,360 |
| Inventories | 6,703 | 6,640 | 8,444 | 8,272 |
| Due from related parties | - | - | - | 293 |
| Due from related parties-Related Party | 18 | 204 | 424 | - |
| Prepaid expenses and other current assets-Nonrelated Party | 31,451 | 23,270 | 19,646 | - |
| Prepaid expenses and other current assets (including amounts with related parties) | - | - | - | 23,852 |
| Prepaid expenses and other current assets-Related Party | 1,496 | 2,234 | 2,029 | - |
| Total current assets | 329,497 | 208,132 | 109,163 | 184,586 |
| Marketable securities, noncurrent | - | - | - | 0 |
| Property, plant and equipment, net | 129,597 | 133,004 | 135,270 | 137,094 |
| Goodwill and intangible assets, net | 14,475 | 14,977 | 15,443 | 15,933 |
| Convertible note receivable | 7,317 | 7,254 | 7,192 | 7,130 |
| Operating lease right-of-use assets, net-Nonrelated Party | 19,273 | 20,103 | 16,482 | - |
| Operating lease right-of-use assets, net-Related Party | 13,922 | 14,620 | 15,298 | - |
| Operating lease right-of-use assets, net (including amounts with related parties) | - | - | - | 33,363 |
| Other assets-Nonrelated Party | 4,473 | 3,553 | 4,533 | - |
| Other assets (including amounts with related parties) | - | - | - | 4,827 |
| Other assets-Related Party | 433 | 433 | 378 | - |
| Total assets | 518,987 | 402,076 | 303,759 | 382,933 |
| Accounts payable-Nonrelated Party | 5,773 | 7,419 | 13,501 | 6,725 |
| Accrued expenses and other liabilities | 43,602 | 35,705 | 27,889 | 40,580 |
| Operating lease liabilities-Nonrelated Party | 3,770 | 3,682 | 3,876 | - |
| Operating lease liabilities-Related Party | 3,546 | 3,710 | 3,584 | - |
| Accounts payable-Related Party | 443 | 128 | 355 | 173 |
| Operating lease liabilities (including amounts with related parties) | - | - | - | 7,466 |
| Total current liabilities | 57,134 | 50,644 | 49,205 | 54,944 |
| Related-party nonconvertible note, net of discount (note 12) | - | - | - | 0 |
| Related-party convertible notes and accrued interest, net of discount (note 12) | - | - | - | 0 |
| Related-party convertible note payable, at fair value (note7 and note12) | - | - | - | 461,877 |
| Related-party convertible note payable, at fair value (note 9 and note 14)-Related Party | 500,804 | 492,084 | 485,717 | - |
| Revenue interest liability (note13) | 316,145 | 307,049 | 296,287 | 284,404 |
| Operating lease liabilities, less current portion-Nonrelated Party | 19,805 | 20,798 | 17,077 | - |
| Operating lease liabilities, less current portion-Related Party | 14,325 | 15,042 | 16,020 | - |
| Derivative liabilities (note13) | 18,322 | 18,611 | 20,542 | 25,800 |
| Operating lease liabilities, less current portion (including amounts with related parties) | - | - | - | 34,823 |
| Warrant liabilities (note16) | 115,160 | 66,957 | 9,023 | 8,575 |
| Other liabilities | 702 | 710 | 370 | 639 |
| Total liabilities | 1,042,397 | 971,895 | 894,241 | 871,062 |
| Common stock, 0.0001par value 1,350,000,000shares authorized as of september30,2025 and december31,2024 984,965,179 and 852,904,340shares issued and outstanding as of september30,2025 and december31,2024, respectively excluding treasury stock, 163,800shares outstanding as of september30,2025 and december31,2024 | 98 | 91 | 85 | 85 |
| Additional paid-in capital | 3,135,288 | 3,014,041 | 2,893,422 | 2,884,867 |
| Accumulated deficit | -3,664,702 | -3,597,449 | -3,504,894 | -3,375,248 |
| Accumulated other comprehensive income | 4,997 | 12,568 | 19,956 | 1,198 |
| Total immunitybio stockholders deficit | -524,319 | -570,749 | -591,431 | -489,098 |
| Noncontrolling interests | 909 | 930 | 949 | 969 |
| Total stockholders deficit | -523,410 | -569,819 | -590,482 | -488,129 |
| Total liabilities and stockholders deficit | 518,987 | 402,076 | 303,759 | 382,933 |
ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX)